Associate Scientific Director
Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Disclosure(s): AstraZeneca: The IDCRP and HJF were funded to conduct an unrelated phase III COVID-19 monoclonal antibody immunoprophylaxis trial as part of US Govt COVID Response
Dr Simon Pollett is employed by the Henry Jackson Foundation as the Associate Science Director and COVID-19 Research Area Director of the Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences (USUHS), Bethesda, Maryland. His research interests include the epidemiology and countermeasure development for emerging respiratory and vector-borne viruses.